Your browser doesn't support javascript.
loading
RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.
Chen, Lei; Zhang, Wenjing; Chen, Dan; Yang, Quan; Sun, Siwen; Dai, Zhenwei; Li, Zhengzheng; Liang, Xuemei; Chen, Chaoqun; Jiao, Yuexia; Zhi, Lili; Zhao, Lianmei; Zhang, Jinrui; Liu, Xuefeng; Zhao, Jinyao; Li, Man; Wang, Yang; Qi, Yangfan.
Afiliação
  • Chen L; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China.
  • Zhang W; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China.
  • Chen D; Department of Pathology, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.
  • Yang Q; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China.
  • Sun S; Department of Oncology, the Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
  • Dai Z; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China.
  • Li Z; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China.
  • Liang X; Department of Thoracic Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.
  • Chen C; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China.
  • Jiao Y; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China.
  • Zhi L; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China.
  • Zhao L; Research Center, the Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
  • Zhang J; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China.
  • Liu X; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China.
  • Zhao J; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China.
  • Li M; Department of Oncology, the Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China. liman126126@163.com.
  • Wang Y; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China. yangwang@dmu.edu.cn.
  • Qi Y; Institute of Cancer Stem Cells and the Second Affiliated Hospital of Dalian Medical University, Dalian Medical University, Dalian, 116044, China. yangfanqi@dmu.edu.cn.
Signal Transduct Target Ther ; 8(1): 159, 2023 04 21.
Article em En | MEDLINE | ID: mdl-37080995
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Limite: Humans Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Limite: Humans Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China